FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

1145415004: Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)


Status: current, Defined. Date: 31-Jul 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4545858010 Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core
4545859019 Carbidopa 50 mg and levodopa 200 mg prolonged-release oral tablet en Synonym Active Case insensitive SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Carbidopa 50 mg and levodopa 200 mg prolonged-release oral tablet Plays role Antiparkinson therapeutic role true Inferred relationship Some
Carbidopa 50 mg and levodopa 200 mg prolonged-release oral tablet Has unit of presentation Tablet true Inferred relationship Some
Carbidopa 50 mg and levodopa 200 mg prolonged-release oral tablet Is a Carbidopa and levodopa only product in oral dose form true Inferred relationship Some
Carbidopa 50 mg and levodopa 200 mg prolonged-release oral tablet Has manufactured dose form Extended-release oral tablet true Inferred relationship Some
Carbidopa 50 mg and levodopa 200 mg prolonged-release oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 1
Carbidopa 50 mg and levodopa 200 mg prolonged-release oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 1
Carbidopa 50 mg and levodopa 200 mg prolonged-release oral tablet Has BoSS Levodopa true Inferred relationship Some 1
Carbidopa 50 mg and levodopa 200 mg prolonged-release oral tablet Has precise active ingredient Levodopa true Inferred relationship Some 1
Carbidopa 50 mg and levodopa 200 mg prolonged-release oral tablet Has precise active ingredient Carbidopa true Inferred relationship Some 2
Carbidopa 50 mg and levodopa 200 mg prolonged-release oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 2
Carbidopa 50 mg and levodopa 200 mg prolonged-release oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 2
Carbidopa 50 mg and levodopa 200 mg prolonged-release oral tablet Has BoSS Carbidopa true Inferred relationship Some 2

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Description inactivation indicator reference set

Back to Start